The Valley Desk

ArticleAdvances in therapyPublished

Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Humans; Pemphigoid, Bullous; Treatment Outcome; Double-Blind Method; Adult; Aged; Middle Aged; Female; Male; Randomized Controlled Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic
PubMed ID
38443648
PubMed Central ID
PMC11213798
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal